Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis
remains out of control in several parts of the world including Africa and Asia. Although …

Background The Xpert MTB/RIF test for tuberculosis is being rolled out in many countries, but
evidence is lacking regarding its implementation outside laboratories, ability to inform same…

Rationale: Xpert MTB/RIF is a novel automated molecular diagnostic recently endorsed by
the World Health Organization. However, performance-related data from high HIV prevalence …

Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting
economically active young adults, and has high mortality irrespective of HIV status. In some …

Background HIV-associated tuberculosis is difficult to diagnose and results in high mortality.
Frequent extra-pulmonary presentation, inability to obtain sputum, and paucibacillary …

Background While tuberculosis incidence and mortality are declining in South Africa, meeting
the goals of the End TB Strategy requires an invigorated programmatic response informed …

Background Improved genetic understanding of Mycobacterium tuberculosis (MTB)
resistance to novel and repurposed anti-tubercular agents can aid the development of rapid …

Background Drug-resistant tuberculosis (DR-TB) is undermining TB control in South Africa.
However, there are hardly any data about the cost of treating DR-TB in high burden settings …

Diagnosis represents only one aspect of tuberculosis ( TB ) control but is perhaps one of the
most challenging. The drawbacks of current tools highlight several unmet needs in TB …

Background Tuberculous meningitis (TBM) is difficult to diagnose promptly. The utility of the
Xpert MTB/RIF test for the diagnosis of TBM remains unclear, and the effect of host- and …